Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients

Pediatrics

Volumn 120, Issue 1, 2007, Pages

  Lindemulder, Susan ^a,b   Albano, Edythe ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Chemoprophylaxis; Leukemia; Lymphoma; Pediatrics; Pneumocystis carinii (jiroveci); Trimethoprim sulfamethoxazole

Indexed keywords

COTRIMOXAZOLE; DAPSONE; PENTAMIDINE;

CHILDHOOD CANCER; COMORBIDITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; HUMAN; LEUKEMIA; LYMPHOMA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; NEUTROPENIA; PATIENT COMPLIANCE; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RASH; REVIEW; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

ANTI-INFECTIVE AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; HUMANS; LEUKEMIA; LYMPHOMA; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PNEUMONIA, PNEUMOCYSTIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 34447116284     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1360     Document Type: Review

References (19)

1. Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1977;297:1419-1426
2. Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1987;316:1627-1632
3. Wilber RB, Feldman S, Malone WJ, Ryan M, Aur RJA, Hughes WT. Chemoprophylaxis for Pneumocystis carinii pneumonitis: outcome of unstructured delivery. Am J Dis Child. 1980;134:643-648
4. Harris RE, McCallister JA, Allen SA, Barton AS, Baehner RL. Prevention of Pneumocystis pneumonia: use of continuous sulfamethoxazole-trimethoprim therapy. Am J Dis Child. 1980;134:35-38
5. Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487-2498
6. Chagas C. New human trypanosomes [in Portuguese]. Mem Inst Oswaldo Cruz. 1909;1:159-218
7. Carini A. Eshizogonia forms of the Trypanosoma lewisi [in Portuguese]. Soc Med Cir Sao Paulo. 1910;38:8
8. Delanoe P, Delanoe M. On the reports of carini in the lung of rats with Trypanosoma lewisi [in French]. CR Acad Sci. 1912;155:658-661
9. Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature. 1988;334:519-521
10. Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis. 2002;8:891-896
11. Hughes WT. Pneumocystis carinii vs Pneumocystis jiroveci: another misnomer. Emerg Infect Dis. 2003;9:276-277
12. Gigliotti F. Pneumocystis carinii: has the name really been changed? Clin Infect Dis. 2005;41:1752-1755
13. Perera DR, Western KA, Johnson HD, et al. Pneumocystis carinii pneumonia in a hospital for children. Epidemiologic aspects. JAMA. 1970;214:1074-1078
14. Hughes WT, Price RA, Kim HK, Coburn TP, Grigsby D, Feldman S. Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr. 1973;82:404-415
15. Munoz P, Munoz RM, Palomo J, Rodriguez-Creixems M, Munoz R, Bouza E. Pneumocystis carinii infection in heart transplant recipients: efficacy of a weekend prophylaxis schedule. Medicine (Baltimore). 1997;76:415-422
16. Souza JP, Boeckh M, Gooley TA, Flowers ME, Crawford SW. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clin Infect Dis. 1999;29:1467-1471
17. Asmar BI, Maqbool S, Dajani AS. Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children. Am J Dis Child. 1981;135:1100-1103
18. Poulsen A, Demeny AK, Plum CB, Nielsen KG, Schmiegelow K. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 2001;37:20-23
19. Woods WG, Daigle AE, Hutchinson RJ, Robison LL. Myelosuppression associated with co-trimoxazole as a prophylactic antibiotic in the maintenance phase of childhood acute lymphocytic leukemia. J Pediatr. 1984;105:639-644